Corbus Pharmaceuticals Holdings Inc
(LTS:0SZI)
$
40.937
-5.0081 (-10.9%)
Market Cap: 468.18 Mil
Enterprise Value: 365.37 Mil
PE Ratio: 0
PB Ratio: 4.27
GF Score: 28/100 Corbus Pharmaceuticals Holdings Inc (LTS:0SZI) Transcripts
- Corbus Pharmaceuticals Holdings Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Corbus Pharmaceuticals Holdings Inc Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases Corporate Call TranscriptJun 01, 2021
- Q4 2020 Corbus Pharmaceuticals Holdings Inc Earnings Call TranscriptMar 15, 2021$69.6 (+5.22%)Earnings
- Q3 2020 Corbus Pharmaceuticals Holdings Inc Earnings Call TranscriptNov 10, 2020$32.4 (-3.57%)Earnings
- Corbus Pharmaceuticals Holdings, Inc. - Special Call TranscriptSep 08, 2020
- Q2 2020 Corbus Pharmaceuticals Holdings Inc Earnings Call TranscriptAug 06, 2020$194.08 (-8.62%)Earnings
- Q1 2020 Corbus Pharmaceuticals Holdings Inc Earnings Call TranscriptMay 11, 2020$197.69Earnings
- Q4 2019 Corbus Pharmaceuticals Holdings Inc Earnings Call TranscriptMar 12, 2020$197.69Earnings
- Corbus Pharmaceuticals Holdings, Inc. - Special Call TranscriptDec 13, 2019
- Q3 2019 Corbus Pharmaceuticals Holdings Inc Earnings Call TranscriptNov 07, 2019$162Earnings
- Q2 2019 Corbus Pharmaceuticals Holdings Inc Earnings Call TranscriptAug 08, 2019$178.2Earnings
- Corbus Pharmaceuticals Holdings Inc to Provide an Overview and Clinical Update for Lenabasum Conference Call TranscriptJun 21, 2019
- Q1 2019 Corbus Pharmaceuticals Holdings Inc Earnings Call TranscriptMay 09, 2019$215.4Earnings
- Full Year 2018 Corbus Pharmaceuticals Holdings Inc Earnings Call TranscriptMar 12, 2019$184.8Earnings
- 1